• No results found

Pharmaceutical Benefits Scheme

Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008–2012

Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008–2012

... Australia’s Pharmaceutical Benefits Scheme (PBS) dispensing claims of HER2-positive early breast cancer patients with medicines prescribed and administered to determine the accuracy of dispensing ...

9

Using Australian Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: challenges and approaches

Using Australian Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: challenges and approaches

... The Pharmaceutical Benefits Scheme (PBS) dataset provides detailed information about subsidised medicines dispensed in Australia and is increasingly used for pharmacoepidemiological ...

6

Trends and Outcomes in the Australian Pharmaceutical Benefits Scheme

Trends and Outcomes in the Australian Pharmaceutical Benefits Scheme

... the Pharmaceutical Benefits Scheme (PBS) to the Government has been the subject of regular controversy and policy responses for a number of ...

31

ACCOUNTING FOR GROWTH IN THE PHARMACEUTICAL BENEFITS SCHEME

ACCOUNTING FOR GROWTH IN THE PHARMACEUTICAL BENEFITS SCHEME

... the pharmaceutical industry is among the highest of any sector of the ...reason pharmaceutical companies have invested heavily in technologies and techniques to improve success rates, increase productivity, ...

338

Trends in the Use and Cost of Pharmaceuticals Under the Pharmaceutical Benefits Scheme

Trends in the Use and Cost of Pharmaceuticals Under the Pharmaceutical Benefits Scheme

... The Pharmaceutical Benefits Advisory Committee (PBAC) is an independent statutory body established in 1954 to make recommendations and give advice to the Minister for Health and Aged Care about which drugs ...

28

Cost driver analysis of statin expenditure on Australia’s pharmaceutical benefits scheme

Cost driver analysis of statin expenditure on Australia’s pharmaceutical benefits scheme

... When atorvastatin was originally listed on the PBS in 1998, it accounted for 23.7% of total statin utilisation in that calendar year. By 2013, atorvastatin and rosuvastatin accounted for 83.2% of total statin utilisation ...

22

Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) database

Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) database

... Thus, we previously developed a new method for calculating adherence to multiple medications from dispensing data, the daily polypharmacy pos- session ratio (DPPR).. 23 This method ca[r] ...

14

Demand and Price Dynamics within the Pharmaceutical Benefits Scheme

Demand and Price Dynamics within the Pharmaceutical Benefits Scheme

... against pharmaceutical costs, such as the pharmacy benefit managers in the US, often specify the use of generic drugs either as a condition of coverage or in guidelines to participating ...

47

Price and Quantity Trends in the Pharmaceutical Benefits Scheme

Price and Quantity Trends in the Pharmaceutical Benefits Scheme

... The analysis undertaken in this paper is based on a database provided by the Pharmaceutical Access and Quality (PAQ) Branch of the Department of Health and Aged Care. The database covers the period 1991-92 to ...

22

Key Aspects of the Australian Pharmaceutical Benefits Scheme

Key Aspects of the Australian Pharmaceutical Benefits Scheme

... Services Scheme provides access to products and services needed for the self-management of diabetes at subsidised prices and includes syringes, insulin infusion pump consumables and glucose testing ...

54

Medication adherence perspectives in haemodialysis patients: a qualitative study

Medication adherence perspectives in haemodialysis patients: a qualitative study

... Medicines in Australia are supplied at a subsidised cost through the Pharmaceutical Benefits Scheme (PBS). How- ever, access to some specialised medicines routinely used in dialysis patients (such as ...

9

An ethical framework for public health immunisation programs

An ethical framework for public health immunisation programs

... the Pharmaceutical Benefits Scheme largely, but not exclusively, on cost-effectiveness ...ceutical Benefits Advisory Committee considers the esti- mated cost per quality-adjusted life year ...

5

An analysis of the government industry relationship in the British pharmaceutical price regulation scheme

An analysis of the government industry relationship in the British pharmaceutical price regulation scheme

... include pharmaceutical products, medical devices, diagnostic techniques, and procedures, as well as the clinical management of specific conditions, and to issue advice to health care ...

337

Determinants of Scheme Design in Occupational Defined Contribution Schemes in Kenya

Determinants of Scheme Design in Occupational Defined Contribution Schemes in Kenya

... most scheme members would be better off by investing in passive index funds and paying the much lower fund management fees that passive managers charged (Malkiel, ...

173

Feasibility and added value of a European Unemployment benefits scheme  CEPS Research Report

Feasibility and added value of a European Unemployment benefits scheme CEPS Research Report

... EUBS benefits would be assimilated into that of NUBS ...security benefits, notably in the family and healthcare ...unemployment benefits generates entitlements in other ...unemployment ...

113

The Stabilisation Properties of a European Unemployment Benefits Scheme  CEPS Commentary September 2016

The Stabilisation Properties of a European Unemployment Benefits Scheme. CEPS Commentary September 2016

... Benefit Scheme”, reached the conclusion that a treaty revision might not be needed if there were sufficient political ...collecting benefits and paying out) could serve to establish a genuine ...

7

Farmers' Attitude towards Kisan Credit Card (KCC) Scheme   The Case of Sivagangai Taluk in Tamilnadu

Farmers' Attitude towards Kisan Credit Card (KCC) Scheme The Case of Sivagangai Taluk in Tamilnadu

... The Factor Analytical Approach has been used to categorise the factors that influenced the farmers’ opinion on the implementation of the KCC Scheme. The statistical approach is a way of condensing the information ...

6

Factors affecting the implementation of strategic change in defined benefits pension scheme: The case of local authorities pension trust.

Factors affecting the implementation of strategic change in defined benefits pension scheme: The case of local authorities pension trust.

... FACTORS AFFECTING THE IMPLEMENTATION OF STRATEGIC CHANGE IN DEFINED BENEFITS PENSION SCHEME: THE CASE OF LuCAL AUTHORITIES.. PENSION TRUST.[r] ...

74

Social security for migrant workers - Greece. Guide concerning the rights and obligations with regard to social security of employed persons going to work in Greece. Guide No. 1, 1982

Social security for migrant workers - Greece. Guide concerning the rights and obligations with regard to social security of employed persons going to work in Greece. Guide No. 1, 1982

... Under the Greek social security scheme for employed persons the following benefits are available: sickness and maternity benefits; - benefits in respect of invalidity, old age and surviv[r] ...

65

Evaluating the multiple benefits of a sustainable drainage scheme in Newcastle, UK

Evaluating the multiple benefits of a sustainable drainage scheme in Newcastle, UK

... high potential to improve habitat size by connecting the large areas of existing greenspace with new greenspace in areas cur- rently classified as ‘ grey ’ infrastructure (buildings, roads, pave- ments) (Figure 9(a)). ...

12

Show all 10000 documents...

Related subjects